Humacyte, Inc. (HUMA)
NASDAQ: HUMA · IEX Real-Time Price · USD
7.55
-0.19 (-2.39%)
At close: Jul 19, 2024, 4:00 PM
7.72
+0.17 (2.25%)
Pre-market: Jul 22, 2024, 7:50 AM EDT
Humacyte Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Humacyte stock have an average target of 7.67, with a low estimate of 3.00 and a high estimate of 15. The average target predicts an increase of 1.59% from the current stock price of 7.55.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Humacyte stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 5 | 5 | 5 | 5 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Strong Buy Maintains $8 → $11 | Strong Buy | Maintains | $8 → $11 | +45.70% | Jul 15, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $7 | Buy | Reiterates | $7 | -7.28% | Jul 2, 2024 |
| Benchmark | Benchmark | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +98.68% | Jul 2, 2024 |
| Benchmark | Benchmark | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +98.68% | May 24, 2024 |
| Benchmark | Benchmark | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +98.68% | May 13, 2024 |
Financial Forecast
Revenue This Year
3.01M
Revenue Next Year
31.46M
from 3.01M
Increased by 946.33%
EPS This Year
-1.01
from -1.07
EPS Next Year
-0.84
from -1.01
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 6.4M | 44.7M | 154.7M | 310.8M | 531.1M |
| Avg | 3.0M | 31.5M | 101.2M | 201.9M | 334.9M |
| Low | 490,000 | 12.3M | 64.1M | 132.4M | 213.1M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | 1,387.5% | 391.6% | 207.1% | 163.1% |
| Avg | - | 946.3% | 221.6% | 99.5% | 65.9% |
| Low | - | 308.3% | 103.7% | 30.8% | 5.5% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.96 | -0.60 | 0.04 | -0.28 | 0.19 |
| Avg | -1.01 | -0.84 | -0.36 | -0.28 | 0.18 |
| Low | -1.05 | -0.95 | -0.60 | -0.26 | 0.18 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.